Breast cancer screening in the Czech Republic: Time trends in performance indicators during the first seven years of the organised programme

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Majek, Ondrej ^a   Danes, Jan ^b   Skovajsova, Miroslava ^c   Bartonkova, Helena ^d   Buresova, Lucie ^a   Klimes, Daniel ^a   Brabec, Petr ^a   Kozeny, Pavel ^e   Dusek, Ladislav ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Association of Czech Breast Radiologists   (Czech Republic)

^d MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^e National Reference Centre   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; CZECH REPUBLIC; FEMALE; HEALTH CARE QUALITY; HEALTH PROMOTION; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; REGISTER; UTILIZATION REVIEW;

AGED; BREAST NEOPLASMS; CZECH REPUBLIC; FEMALE; HEALTH PROMOTION; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PROGRAM EVALUATION; QUALITY INDICATORS, HEALTH CARE; REGISTRIES;

EID: 79955706672     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-288     Document Type: Article

References (55)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. L Dusek, et al. Czech Cancer Care in Numbers 2008-2009 Praha: Grada Publishing, a.s 2009
3. Closing the gap: cancer in Central and Eastern Europe (CEE). W Zatonski J Didkowska, Eur J Cancer 2008 44 1425 1437 10.1016/j.ejca.2008.02.014 18358713
4. Breast cancer screening with mammography: overview of Swedish randomised trials. L Nystrom LE Rutqvist S Wall A Lindgren M Lindqvist S Ryden I Andersson N Bjurstam G Fagerberg J Frisell, et al. Lancet 1993 341 973 978 10.1016/0140-6736(93)91067-V 8096941 (Pubitemid 23109165)
5. Screening for breast cancer with mammography. PC Gotzsche M Nielsen, Cochrane Database Syst Rev 2009 D001877
6. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. HD Nelson K Tyne A Naik C Bougatsos BK Chan L Humphrey, Ann Intern Med 2009 151 727 737 W237-742 19920273
7. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. S Shapiro EA Coleman M Broeders M Codd H de Koning J Fracheboud S Moss E Paci S Stachenko R Ballard-Barbash, Int J Epidemiol 1998 27 735 742 10.1093/ije/27.5.735 9839727
8. L Karsa A Anttila G Ronco A Ponti N Malila M Arbyn N Segnan M Castillo-Beltran M Boniol J Ferlay, et al. Cancer Screening in the European Union: Report on the implementation of the Council Recommendation on cancer screening Luxembourg: European Communities 2008
9. How effective are breast cancer screening programmes by mammography? Review of the current evidence. D Schopper C de Wolf, Eur J Cancer 2009 45 1916 1923 10.1016/j.ejca.2009.03.022 19398327
10. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force, Ann Intern Med 2009 151 716 726 W-236 19920272
11. N Perry M Broeders C de Wolf S Tornberg R Holland L von Karsa E Puthaar (Eds), European guidelines for quality assurance in breast cancer screening and diagnosis, 4th ed Luxembourg: Office for Official Publications of the EC 2006
12. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition - summary document. N Perry M Broeders C de Wolf S Tornberg R Holland L von Karsa, Ann Oncol 2008 19 614 622 18024988 (Pubitemid 351461029)
13. H Vainio F Bianchini, Breast Cancer Screening Lyon: IARCPress 2002
14. Breast cancer screening programmes: the development of a monitoring and evaluation system. NE Day DR Williams KT Khaw, Br J Cancer 1989 59 954 958 10.1038/bjc.1989.203 2736233 (Pubitemid 19155717)
15. Performance of opportunistic breast cancer screening in Slovenia. K Hertl M Primic-Zakelj J Zgajnar I Kocijancic, Neoplasma 2006 53 237 241 16652194 (Pubitemid 43844383)
16. The organisation and results of first screening round of the Hungarian nationwide organised breast cancer screening programme. I Boncz A Sebestyen L Dobrossy Z Pentek A Budai A Kovacs C Dozsa I Ember, Ann Oncol 2007 18 795 799 17259642 (Pubitemid 46523287)
17. The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities. I Boncz A Sebestyen I Pinter I Battyany I Ember, J Med Screen 2008 15 14 17 10.1258/jms.2008.007070 18416949 (Pubitemid 351629540)
18. American College of Radiology, Illustrated breast imaging reporting and data system Reston, VA: American College of Radiology 1998
19. The Tabar classification of mammographic parenchymal patterns. IT Gram E Funkhouser L Tabar, Eur J Radiol 1997 24 131 136 10.1016/S0720-048X(96)01138-2 9097055 (Pubitemid 27165353)
20. Epidemiology of Malignant Tumours in the Czech Republic. http://www.svod.cz/
21. O Jensen DM Parkin R MacLennan C Muir R Skeet, Cancer Registration: Principles and Methods Lyon: International Agency for Research on Cancer 1991
22. Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program. L Kan IA Olivotto LJ Warren Burhenne EA Sickles AJ Coldman, Radiology 2000 215 563 567 11037466 (Pubitemid 30237860)
23. StataCorp, Stata Statistical Software: Release 10 College Station, TX: StataCorp LP 2007
24. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. T Sarkeala S Heinavaara A Anttila, Int J Cancer 2008 122 614 619 10.1002/ijc.23070 17847022 (Pubitemid 350308954)
25. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. R Gabe L Tryggvadottir BF Sigfusson GH Olafsdottir K Sigurdsson SW Duffy, Acta Radiol 2007 48 948 955 10.1080/02841850701501725 18080359 (Pubitemid 350022989)
26. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. SJ Otto J Fracheboud CW Looman MJ Broeders R Boer JH Hendriks AL Verbeek HJ de Koning, Lancet 2003 361 1411 1417 10.1016/S0140-6736(03)13132-7 12727393 (Pubitemid 36515040)
27. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. RG Blanks SM Moss CE McGahan MJ Quinn PJ Babb, BMJ 2000 321 665 669 10.1136/bmj.321.7262.665 10987769
28. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. AH Olsen SH Njor I Vejborg W Schwartz P Dalgaard MB Jensen UB Tange M Blichert-Toft F Rank H Mouridsen E Lynge, BMJ 2005 330 220 10.1136/bmj.38313.639236.82 15649904
29. Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis. E Paci E Coviello G Miccinesi D Puliti L Cortesi V De Lisi S Ferretti L Mangone V Perlangeli A Ponti, et al. Eur J Cancer 2008 44 858 865 10.1016/j.ejca.2008.02.026 18359222
30. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme. EN Ascunce C Moreno-Iribas A Barcos Urtiaga E Ardanaz M Ederra Sanz J Castilla N Egues, J Med Screen 2007 14 14 20 10.1258/096914107780154558 17362566 (Pubitemid 46440360)
31. Reduction in breast cancer mortality from the organized service screening with mammography: 1. Further confirmation with extended data. SOSSEG, Cancer Epidemiol Biomarkers Prev 2006 15 45 51 16434585
32. Reduction in breast cancer mortality from the organised service screening with mammography: 2. Validation with alternative analytic methods. SOSSEG, Cancer Epidemiol Biomarkers Prev 2006 15 52 56 16434586
33. Quality assurance for screening mammography: an international comparison. C Klabunde F Bouchard S Taplin A Scharpantgen R Ballard-Barbash, J Epidemiol Community Health 2001 55 204 212 10.1136/jech.55.3.204 11160176 (Pubitemid 32163569)
34. Quality assurance for screening mammography data collection systems in 22 countries. CN Klabunde H Sancho-Garnier M Broeders S Thoresen VJ Rodrigues R Ballard-Barbash, Int J Technol Assess Health Care 2001 17 528 541 11758297 (Pubitemid 33108647)
35. Overdiagnosis and breast cancer screening. NE Day, Breast Cancer Res 2005 7 228 229 10.1186/bcr1321 16168144 (Pubitemid 41387437)
36. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. KJ Jorgensen PC Gotzsche, Bmj 2009 339 2587 10.1136/bmj.b2587 19589821
37. Cancer screening in Spain. N Ascunce D Salas R Zubizarreta R Almazan J Ibanez M Ederra, Ann Oncol 2010 21 Suppl 3 ii43 51 20427360
38. Results from the UK NHS Breast Screening Programme 2000-05. RL Bennett RG Blanks J Patnick SM Moss, J Med Screen 2007 14 200 204 10.1258/ 096914107782912068 18078565 (Pubitemid 350223784)
39. Early outcome of mammography screening in Copenhagen 1991-99. I Vejborg AH Olsen MB Jensen F Rank UB Tange E Lynge, J Med Screen 2002 9 115 119 10.1136/jms.9.3.115 12370322 (Pubitemid 35205233)
40. Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. T Sarkeala A Anttila H Forsman T Luostarinen I Saarenmaa M Hakama, Eur J Cancer 2004 40 2116 2125 10.1016/j.ejca.2004.06.017 15341987 (Pubitemid 39165546)
41. A breast cancer screening programme operating in a liberal health care system: the Luxembourg Mammography Programme, 1992-1997. P Autier F Shannoun A Scharpantgen C Lux C Back G Severi S Steil D Hansen-Koenig, Int J Cancer 2002 97 828 832 10.1002/ijc.10161 11857363 (Pubitemid 34106340)
42. Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening. W Oberaigner W Buchberger T Frede R Knapp C Marth U Siebert, BMC Public Health 10 86
43. Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark. K Bihrmann A Jensen AH Olsen S Njor W Schwartz I Vejborg E Lynge, J Med Screen 2008 15 23 26 10.1258/jms.2008.007055 18416951 (Pubitemid 351629542)
44. Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study. A Bordoni NM Probst-Hensch L Mazzucchelli A Spitale, Br J Cancer 2009 101 1925 1931 10.1038/sj.bjc.6605378 19861962
45. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. R de Gelder JL Bulliard C de Wolf J Fracheboud G Draisma D Schopper HJ de Koning, Eur J Cancer 2009 45 127 138 10.1016/j.ejca.2008.09.015 19038540
46. Effectiveness of organised versus opportunistic mammography screening. JL Bulliard C Ducros C Jemelin B Arzel G Fioretta F Levi, Ann Oncol 2009 20 1199 1202 10.1093/annonc/mdn770 19282467
47. Who gets screened, and where: a comparison of organised and opportunistic mammography screening in Geneva, Switzerland. E Chamot AI Charvet TV Perneger, Eur J Cancer 2007 43 576 584 10.1016/j.ejca.2006.10.017 17223542 (Pubitemid 46177589)
48. Do nonattenders in mammography screening programmes seek mammography elsewhere? A Jensen AH Olsen M von Euler-Chelpin S Helle Njor I Vejborg E Lynge, Int J Cancer 2005 113 464 470 10.1002/ijc.20604 15455383 (Pubitemid 40038716)
49. Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000. MJ Broeders A Scharpantgen N Ascunce B Gairard AH Olsen P Mantellini TC Mota E Van Limbergen B Seradour A Ponti, et al. Eur J Cancer Prev 2005 14 107 116 10.1097/00008469-200504000-00006 15785314 (Pubitemid 40516972)
50. Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer. AA Sahin M Guray KK Hunt, Arch Pathol Lab Med 2009 133 869 878 19492879
51. Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group. AH Madsen AR Jensen P Christiansen JP Garne S Cold M Ewertz J Overgaard, Acta Oncol 2008 47 239 247 10.1080/02841860701727436 18210299
52. Estimation of sojourn time in chronic disease screening without data on interval cases. TH Chen HS Kuo MF Yen MS Lai L Tabar SW Duffy, Biometrics 2000 56 167 172 10.1111/j.0006-341X.2000.00167.x 10783792 (Pubitemid 30165105)
53. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Brett J Austoker G Ong, J Public Health Med 1998 20 396 403 9923945 (Pubitemid 29017247)
54. Reporting of performance indicators of mammography screening in Europe. E Lynge AH Olsen J Fracheboud J Patnick, Eur J Cancer Prev 2003 12 213 222 10.1097/00008469-200306000-00008 12771560 (Pubitemid 36686748)
55. Time trends of some indicators of mammography screening programmes in Italy, 1996-2003. L Giordano D Giorgi P Piccini V Stefanini R Castagno C Senore, Epidemiol Prev 2006 30 17 26 16937843